Scarica l'app Stockscreener
1.20
2.44%
-0.03
Dopo l'orario di chiusura:
1.20
Precedente Chiudi:
$1.23
Aprire:
$1.24
Volume 24 ore:
347.47K
Relative Volume:
0.14
Capitalizzazione di mercato:
$274.03M
Reddito:
$8.95M
Utile/perdita netta:
$-21.49M
Rapporto P/E:
-10.00
EPS:
-0.12
Flusso di cassa netto:
$-29.24M
1 W Prestazione:
-0.83%
1M Prestazione:
+23.71%
6M Prestazione:
+125.23%
1 anno Prestazione:
+33.41%
Intervallo 1D:
$1.195
$1.24
Intervallo di 1 settimana:
$1.14
$1.25
Portata 52W:
$0.3651
$1.31
Lineage Cell Therapeutics Inc Stock (LCTX) Company Profile
Nome
Lineage Cell Therapeutics Inc
Settore
Industria
Telefono
510-871-4188
Indirizzo
2173 Salk Avenue, Suite 200, Carlsbad, CA
Confronta LCTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LCTX
Lineage Cell Therapeutics Inc
|
1.20 | 278.59M | 8.95M | -21.49M | -29.24M | -0.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Lineage Cell Therapeutics Inc Stock (LCTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-20 | Iniziato | Craig Hallum | Buy |
| 2022-11-02 | Iniziato | Robert W. Baird | Outperform |
| 2022-06-14 | Iniziato | B. Riley Securities | Buy |
| 2021-08-19 | Iniziato | Noble Capital Markets | Outperform |
| 2021-03-31 | Iniziato | Cantor Fitzgerald | Overweight |
Lineage Cell Therapeutics Inc Borsa (LCTX) Ultime notizie
Does Lineage Cell Therapeutics Inc. offer margin of safetyJuly 2025 Price Swings & Reliable Trade Execution Plans - khodrobank.com
Is it too late to sell Lineage Cell Therapeutics Inc.Quarterly Performance Summary & Risk Managed Trade Strategies - Newser
Can technical indicators confirm Lineage Cell Therapeutics Inc.’s reversal2025 Buyback Activity & AI Enhanced Trading Alerts - Newser
How to use Fibonacci retracement on Lineage Cell Therapeutics Inc.2025 Major Catalysts & Real-Time Price Movement Reports - Newser
Evaluating Lineage Cell Therapeutics Inc. with trendline analysisWeekly Market Summary & Fast Momentum Stock Entry Tips - Newser
Spinal Cord Injury Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights By DelveInsight | StemCyte, NervGen Pharma, VA Office of Research and Development - The Globe and Mail
Is Lineage Cell Therapeutics Inc. reversing from oversold territoryWeekly Profit Summary & Consistent Income Trade Ideas - Newser
Applying big data sentiment scoring on Lineage Cell Therapeutics Inc.Quarterly Investment Review & Weekly Hot Stock Watchlists - Newser
Measuring Lineage Cell Therapeutics Inc.’s beta against major indicesWall Street Watch & Free Daily Entry Point Trade Alerts - Newser
Is Lineage Cell Therapeutics Inc. forming a reversal patternJuly 2025 Intraday Action & Long-Term Investment Growth Plans - Newser
Real time scanner hits for Lineage Cell Therapeutics Inc. explainedJuly 2025 Closing Moves & Technical Pattern Based Buy Signals - Newser
New Report: Cell Therapy Manufacturing Market Set for Rapid - openPR.com
What candlestick patterns are forming on Lineage Cell Therapeutics Inc.Volume Spike & Community Verified Swing Trade Signals - Newser
Is Lineage Cell Therapeutics Inc. forming a bottoming baseJuly 2025 Levels & Weekly High Momentum Picks - Newser
Is it time to cut losses on Lineage Cell Therapeutics Inc.July 2025 Review & Entry Point Confirmation Alerts - Newser
Lineage Cell Therapeutics Inc. stock prediction for this weekPortfolio Update Summary & Capital Efficiency Focused Strategies - Newser
Tick level data insight on Lineage Cell Therapeutics Inc. volatilityQuarterly Profit Summary & Detailed Earnings Play Strategies - Newser
Will breakout in Lineage Cell Therapeutics Inc. lead to full recovery2025 Growth vs Value & Scalable Portfolio Growth Methods - Newser
Does Lineage Cell Therapeutics Inc. align with a passive investing strategyJuly 2025 Technicals & Reliable Entry Point Alerts - khodrobank.com
Is Lineage Cell Therapeutics Inc. a play on infrastructure spending2025 Market WrapUp & Safe Entry Trade Reports - khodrobank.com
Spinal Cord Injury Pipeline Analysis, Clinical Trials, 2025 by DelveInsight | EUSOL Biotech, Kringle Pharma, Mitsubishi Tanabe Pharma Corporation, Lineage Cell Therapeutics, NervGen Pharma, AlaMab The - Barchart.com
Is Lineage Cell Therapeutics Inc. stock a value trapMarket Weekly Review & Accurate Entry and Exit Point Alerts - khodrobank.com
Published on: 2025-09-02 15:54:56 - Newser
Should you wait for a breakout in Lineage Cell Therapeutics Inc.2025 Technical Overview & Community Consensus Picks - Newser
Real time pattern detection on Lineage Cell Therapeutics Inc. stockTake Profit & Daily Profit Focused Stock Screening - Newser
Published on: 2025-09-02 13:14:02 - Newser
Comparing Lineage Cell Therapeutics Inc. in custom built stock radarsGlobal Markets & Fast Gain Stock Tips - Newser
Lineage Cell Therapeutics to Present at September 2025 Investor Conferences - Business Wire
What are analysts’ price targets for Lineage Cell Therapeutics Inc.2025 AllTime Highs & Daily Stock Trend Reports - khodrobank.com
Is Lineage Cell Therapeutics Inc. stock a good pick for beginners2025 Price Momentum & Daily Volume Surge Trade Alerts - khodrobank.com
Is Lineage Cell Therapeutics Inc. stock reversal real or fakeDay Trade & Stepwise Swing Trade Plans - Newser
Heatmap analysis for Lineage Cell Therapeutics Inc. and competitorsQuarterly Trade Summary & Daily Volume Surge Trade Alerts - Newser
Is Lineage Cell Therapeutics Inc. stock influenced by commodity pricesJuly 2025 Levels & AI Powered Market Trend Analysis - khodrobank.com
Is Lineage Cell Therapeutics Inc. still worth holding after the dipMarket Sentiment Review & Verified Momentum Watchlists - Newser
What data driven models say about Lineage Cell Therapeutics Inc.’s futureBond Market & Real-Time Stock Movement Alerts - Newser
Should I hold or sell Lineage Cell Therapeutics Inc. now2025 Geopolitical Influence & Weekly Setup with High ROI Potential - khodrobank.com
News impact scoring models applied to Lineage Cell Therapeutics Inc.2025 Earnings Surprises & Safe Entry Point Alerts - Newser
What does recent volatility data suggest for Lineage Cell Therapeutics Inc.Market Activity Recap & Daily Technical Forecast Reports - Newser
Lineage Cell Therapeutics Q2 Earnings Call: Progress Amid Financial Challenges. - AInvest
Lineage Cell Therapeutics’ Earnings Call: Progress Amid Challenges - TipRanks
Lineage Cell Therapeutics Inc. stock outlook for YEAR2025 Support & Resistance & Safe Entry Trade Signal Reports - Newser
Risk adjusted return profile for Lineage Cell Therapeutics Inc. analyzedWeekly Investment Report & Weekly Hot Stock Watchlists - Newser
Identifying reversal signals in Lineage Cell Therapeutics Inc.Portfolio Growth Summary & Daily Growth Stock Tips - Newser
Lineage Cell Therapeutics Inc Azioni (LCTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):